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Abstract
Background: Indians may be particularly vulnerable to cardiometabolic disease, potentially due to higher body fat
for a given BMI, or a tendency towards depositing abdominal adiposity. The aim of the study is to assess whether
different measures of the distribution of adiposity (abdominal versus whole body) or amount of adiposity (DXA
versus traditional anthropometric) are better at predicting prevalent cardiometabolic risk markers in an Indian
population.
Methods: Participants were recruited from the Indian Migration Study (IMS) and the Andhra Pradesh Children and
Parent Study (APCAPS). Participants attended a clinic in Hyderabad, India, January 2009-December 2010. Adiposity
was measured by conventional anthropometry (including weight, height, waist) and DXA scanning (whole body
and abdominal). Blood samples were taken and assessed for fasting plasma glucose, insulin, cholesterol, and
triglycerides and blood pressure was measured. Lifestyle data were collected by questionnaire.
Results: We invited 4 617 participants to the clinic (1 995 IMS; 2 622 APCAPS) and examined 918 from IMS (46%)
and 1 451 from APCAPS (55%). There were strong and consistent relationships between adiposity and
cardiometabolic risk factors. Cardiometabolic risk factors did not appear to be more strongly associated with DXA
measures as opposed to BMI, or skinfold measures of body fat. There was some evidence that WHR was more
closely related to diabetes than total body adiposity, but this was not apparent for the other measures of
abdominal adiposity (DXA measures, waist circumference) or other cardiometablic risk factors.
Conclusions: No strong evidence supports that DXA measures or abdominal measures of adiposity are better at
predicting the prevalence of cardiometabolic risk factors in comparison to BMI.
Keywords: Adiposity, India, Cardiometabolic, Diabetes, Hypertension, Cardiovascular, Dual-energy X-ray
absorptiometry
Background
India is experiencing a rapid increase in the prevalence of
obesity, type 2 diabetes and deaths from cardiovascular
disease (CVD) [1-4]. This epidemic has been attributed to
rising urbanisation [5,6], and consequent changes in pat-
terns of diet [7] and physical activity [8]. Asian countries
have similar prevalence of diabetes to Western countries,
despite lower obesity as measured through Body Mass
Index (BMI) [9]. These ecological data are supported by
observational studies, which suggest that diabetes develops
at lower levels of BMI among Asians compared to Whites
[10,11]. Furthermore, several studies suggest that Indian
men are less insulin sensitive than Whites regardless of
their BMI [12], with insulin resistance occurring even in
lean Indians [13,14] and Indian adolescents [15].
There are several potential explanations for the vulner-
ability among Indians to diabetes and other cardiometa-
bolic diseases. Indians may have higher percentage body
fat for a given BMI compared with White populations
[12,14,16,17], even as newborns [18]. Alternatively, the
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vulnerability may result from a predisposition towards
abdominal adiposity [12-14,19], which may be more
closely linked to risk of cardiometabolic disease than
more general obesity measures [20-22]. A third explan-
ation argues for vulnerability towards diabetes and other
chronic disease among people of Indian descent which is
not related to adiposity [3,9,23], including genetic vari-
ants, though this is still strongly debated [24-29].
The key to unraveling this question is to obtain an ac-
curate measure of adiposity and abdominal adiposity in
an Indian population [30]. Low-technology methods,
such as BMI measurement, may not correspond well to
adiposity, as they are also dependent on the amount of
lean mass and height [17]. Waist-hip ratio (WHR) and
skinfold thickness may be difficult to measure reliably
and hence have a greater degree of non differential mis-
classification which would attenuate associations [30].
Dual-energy X-ray absorptiometry (DXA) scanning pro-
vides precise measures of the amount and distribution of
fat tissue, including abdominal adiposity, through the
differential absorption of X rays of two different ener-
gies. However, the use of DXA scanning in large-scale
population studies adds substantially to costs and com-
plexity so is not feasible in many settings.
The aim of the study is to assess whether different mea-
sures of the distribution of adiposity (abdominal versus
whole body) or amount of adiposity (DXA versus trad-
itional anthropometric) are better at predicting prevalent
cardiometabolic risk markers in an Indian population.
Methods
Study population
The current analyses were based on cross-sectional data
obtained during clinical investigations of participants
from two previously studied cohorts living in the city of
Hyderabad, India, and its surrounding areas.
The Hyderabad arm of the Indian Migration Study
(IMS) is a cohort study constituted of rural to urban mi-
grants and their spouses recruited from a factory in Hy-
derabad and their siblings who had remained in a rural
area [6]. As a control group, factory workers born in
urban areas and their urban siblings were also recruited.
The baseline was conducted between 2005 and 2007,
during which time 1 995 participants were examined in
Hyderabad (overall response rate for IMS 50%).
The Andhra Pradesh Children and Parent Study (APCAPS)
is based on the Hyderabad Nutrition Trial (HNT) con-
ducted in 1987-1990 [31]. The HNT consisted of 2 622
children who were born in 29 villages around Hyderabad
between 1987 and 1990. In half of the villages, pregnant
women and their offspring received food supplementation,
providing 2.51 MJ and 20 g protein to the women and half
this amount to the children. In the control villages they re-
ceived no food supplementation. Between 2003 and 2005,
1165 of the children attended a research clinic [32]. These
children, their parents and siblings now form the APCAPS
cohort.
The participants of these two cohorts were invited to
attend a clinic at the National Institute of Nutrition be-
tween January 2009 and December 2010.
Data collection
Measures of adiposity
DXA scanning Participants underwent whole body dual
energy X-ray absorptiometry (DXA) scans on a Hologic
DXA machine (Discovery A model, 91% of scans) or a
Hologic QDR 4500 Elite machine (9% of scans).
The whole body scan was performed with the partici-
pant supine on the scanning bed with their arms resting
by their sides to provide measures of total body fat (g) and
total body percentage fat (%).The Hologic software also
defined the trunk region, with manual adjustment by a
single DXA technician where necessary. Abdominal body
composition measures were calculated for two regions of
interest: L1-L4 and L2-L4. These regions of interest were
drawn twice on to the whole body scan using the Hologic
software by the same technician and the average estimate
of the two measurements was used in the analyses.
Whole body scans were visually checked for artifacts
and those with major artifacts (e.g. movement artifacts)
were removed from the analyses. For quality assurance,
a spine phantom was scanned every day to check for ac-
ceptable ranges.
Anthropometric data Weight was measured to the
nearest 0.1 kg with digital Seca weighing machine (www.
seca.com) and standing height to the nearest 1 mm with
a plastic stadiometer (Leicester height measure; supplied
by Chasmors, London). Waist circumference (WC) was
measured to the nearest mm using a non-stretch metal
tape at the narrowest point of the abdomen between the
ribs and the iliac crest at the end of expiration and hip
circumference at the widest part of the buttock. Each
measure was assessed twice, and the average was used in
the analysis. We measured skinfold thickness at five sites
(biceps, triceps, subscapular, suprailiac and calf ) in tripli-
cate to the nearest 0.2 mm using the Holtain calliper
(Holtain, Dyfed, UK) and used the average in the ana-
lysis to calculate percent body fat with the Durnin and
Womersley formula, as it was most widely used [33].
Laboratory assessment Participants were asked to at-
tend fasting and the time of the last meal was recorded.
Venous blood samples (20 mL) were collected. IMS par-
ticipants underwent a standard glucose tolerance test,
unless they were diabetic or pregnant, and a second
blood sample was taken after two hours.
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Blood samples, with the exception of glucose assays,
were separated and stored at -20 °C locally and trans-
ported to the Centre for Chronic Disease Control labora-
tory, New Delhi for lipid and insulin analysis. Serum HDL
cholesterol was estimated directly by an elimination method,
total cholesterol by an enzymatic endpoint method, and
triglycerides by GPO-PAP method. Insulin was assessed
by ELISA method using kits from MERCODIA (Uppsala,
Sweden). The quality of local assays was checked with
regular external standards and internal duplicate assays
and monitored by All India Institute of Medical Sciences
(AIIMS). The Cardiac Biochemistry Lab, AIIMS, is part
of the UK National External Quality Assessment (www.
ukneqas.org.uk) programme and External Quality Assess-
ment Scheme from RANDOX for quality assurance of In-
sulin and biochemical assays respectively. Glucose was
measured on the day of the sample collection at the Na-
tional Institute of Nutrition with the GOD-PAP method
using RANDOX kits.
Cardiovascular measures We used a validated oscillo-
metric device (OMRON M5-; Omron, Matsusaka Co,
Japan) to measure systolic blood pressure (SBP) and dia-
stolic blood pressure (DBP) in the sitting position on the
right arm using an appropriate sized cuff after a period
of 5 minutes rest. We took three measurements, 2-3 mi-
nutes apart, and used the average of the last two mea-
surements for analysis.
Questionnaire data Participants were interviewed using
a structured questionnaire. Socioeconomic position was
assessed using a subset of 14 of 29 questions from the
Standard of Living Index (SLI), where a higher score de-
notes higher socioeconomic position. Physical activity
over the past week was assessed based on the average
amount of time and frequency of participation in differ-
ent activities. Diet was measured with a food frequency
questionnaire. Information was also collected about to-
bacco use, alcohol consumption and medical history.
Training and pilot testing
Training of fieldworkers and screening staff was con-
ducted over a two week period and repeated at the mid-
point of the study, which included standardization of the
anthropometrists against a gold standard and assessment
of within and between observer repeatability. A pilot
study was conducted over a one week period.
Statistical analyses
Outcome measures
A diagnosis of diabetes was made using the World
Health Organization fasting plasma glucose criterion of
≥7.0 mmol/l or 2 hour post glucose load ≥11.1 mmol/l
[34], or self report of a diagnosis of diabetes. Impaired
fasting glucose (IFG) was defined by fasting plasma glu-
cose criterion of 6.1-6.9 mmol/l and 2 hour post glucose
load <7.8 mmol/l. Insulin resistance was defined as being
in the top quartile of Homeostasis Model Assessment
(HOMA), excluding diabetic individuals and those who
had not fasted [35]. Hypertension was defined through
self report or blood pressure ≥140/90 mm Hg.
Measures of adiposity
Six measures were used in analyses: DXA measures of i)
total body and ii) abdominal adiposity, anthropometric
measures of iii) BMI, iv) waist-hip ratio, v) waist circum-
ference and vi) body fat based on skinfold thickness (tri-
ceps and subscapular) [33].
Covariates
Metabolic equivalent tasks (METs) and dietary energy
intake were estimated from the questionnaire. We de-
rived an socio-economic status score by weighting the
SLI question items to give a maximum score of 38, using
standard weights [36].
All analyses were conducted in Stata (version 12). All
analyses were performed stratified by study. To allow
comparison between different anthropometric measures,
all measures were converted to sex and study specific
z-scores. Associations with continuously measured
outcomes were investigated using multivariable linear
regression. Multivariable logistic regression was under-
taken for categorical outcomes (diabetes, IFG, insulin
resistance, hypertension), and these analyses were re-
stricted to IMS participants because of the very low
number of cases among the APCAPS subjects. Outcome
measures which were right skewed were log transformed
and results from regression analyses of these variables
are presented as ratios of geometric means. Regression
analyses were adjusted for age, sex, smoking, physical ac-
tivity, socioeconomic class, alcohol consumption and
dietary energy intake. Age was treated as a continuous
variable in the APCAPS study but as a categorical vari-
able in the IMS (<40, 40-49, 50-59, 60+ years) because
there was evidence that the association between age and
adiposity was not linear. DXA measures were also ad-
justed for DXA machine, DXA total fat (grams) and
DXA L1-L4 were additionally adjusted for height. Robust
standard errors were calculated to account for siblings
within the dataset in both cohorts. Analyses were based
on subjects with complete anthropometric and covariate
data. Men and women were analysed together, but we
tested for sex interactions using Likelihood Ratio Tests.
Evidence for statistical heterogeneity in effect estimates
between different measures of adiposity and outcome
measures was assessed by the I2 statistic using the
“metan” command in Stata.
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Ethical approval and consent
Ethical approval was obtained from the AIIMS, the Na-
tional Institute of Nutrition and the London School of
Hygiene & Tropical Medicine. Consent was sought from
the community leaders in the villages for the APCAPS
study, and from the factory managers for the Indian Mi-
grant Study. Informed written consent was collected
from all participants. All participants diagnosed with po-
tential medical conditions were referred for appropriate
management.
Results
We invited 4 617 people (1 995 from IMS and 2 622
from APCAPS) to attend the clinic at the National Insti-
tute of Nutrition and examined 2369 (51%), 918 from
IMS (46%) and 1 451 from APCAPS (55%). Among the
IMS subjects, clinic attendees did not differ in age from
non attendees (47.8 vs 47.2 years, P = 0.15) or by per-
centage female (47% vs 48%, P = 0.82). A higher propor-
tion of clinic attendees were urban dwellers (61% vs
47%, P <0.001). Among the APCAPS participants, clinic
Table 1 Descriptive data for total population (N = 2160)
IMS APCAPS
N Men Women Men Women
n = 438 n = 360 n = 959 n = 412
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age 50.4 (8.6) 47.2 (7.9) 20.8 (1.1) 21.0 (1.2)
SLI1 24.5 (6.1) 24.2 (6.8) 18.6 (4.2) 17.7 (4.5)
METs 38.2 (5.7) 35.3 (5.2) 40.1 (6.5) 36.6 (5.3)
Energy intake 2694 (827) 2027 (568) 3288 (1129) 2066 (627)
Weight (kg) 66.9 (10.9) 61.7 (11.2) 54.8 (8.7) 44.4 (7.4)
Height(cm) 165.0 (6.2) 152.3 (5.7) 166.7 (6.3) 152.6 (5.3)
BMI kg/m2 24.6 (3.6) 26.5 (4.3) 19.7 (2.8) 19.0 (2.9)
WHR 0.93 (0.06) 0.83 (0.06) 0.82 (0.04) 0.76 (0.05)
Waist circumference 87.9 (9.4) 83.1 (10.0) 69.9 (6.9) 64.1 (6.8)
Body fat % (skinfolds) 26.6 (5.3) 35.0 (4.5) 13.4 (4.6) 23.0 (5.5)
DXA Total
fat (g)2
16537 (5364) 23405 (6492) 8776 (4019) 12751 (4244)
DXA L1L4
fat (g)2
2449 (983) 2764 (1051) 853 (531) 1003 (534)
Insulin (mu/l)1,3 5.8 (3.3, 8.55) 6.15 (3.9, 10) 3.8 (2.9, 5.2) 4.0 (2.8, 5.7)
Glucose mmol/L1,3 5.09 (4.72, 5.61) 5.23 (4.81, 5.84) 4.78 (4.47, 5.12) 4.75 (4.47, 5.01)
Triglycerides
mmol/L1
Cholesterol
mmol/L1
4.8 (1.0) 4.9 (1.1) 4.0 (0.9) 4.0 (0.9)
SBP (mm Hg)1 122.2 (14.8) 115.4 (14.5) 117.3 (9.2) 109.5 (9.3)
DBP (mm Hg)1 80.8 (9.6) 77.9 (9.6) 69.6 (7.7) 68.6 (8.0)
N(%) N(%) N(%) N(%)
Smoking
Never 342 (78%) 360 (100%) 837 (87%) 412 (100%)
Former/current 96 (22%) 0 122 (13%) 0
Alcohol (drinks/day)
None 166 (38%) 295 (82%) 263 (27%) 363 (88%)
0 < 1 203 (46%) 61 (17%) 509 (53%) 46 (11%)
1 < 4 57 (13%) 4 (1%) 127 (13%) 2 (0.5%)
≥4 12 (3%) 0 60 (6%) 1 (0.2%)
1Some missing data.
2Geometric mean and 95% CI are presented for APCAPS subjects.
3Glucose and insulin exclude known diabetics and non fasters.
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attendees were similar in age to non attendees (20.1 vs
20.2 years, P = 0.03) but were much more likely to be
male (68% vs 28%, P <0.001).
The APCAPS participants were younger than those
from the IMS (Hyderabad) sample, and had generally
lower SLI (Table 1). Levels of physical activity and total
caloric energy intake were higher in the APCAPS sample
compared with IMS. Smoking and alcohol consumption
were very rare among females from both the APCAPS
and IMS groups. Among men, the prevalence of ever
smoking was higher among the IMS subjects compared
with the APCAPS subjects, while the levels of alcohol
consumption were similar in the two groups and rela-
tively modest. All measures of adiposity, were substan-
tially higher among the IMS participants compared to
those from APCAPS as were glucose, insulin, triglycer-
ides and cholesterol.
The correlation coefficients between the different mea-
sures of adiposity were high in both the IMS and APCAPS
groups, generally exceeding 0.7, with the exception of
WHR (Additional file 1: Tables S1 and S2).
Measures of adiposity were generally associated with
the blood based measures of cardiometabolic risk fac-
tors, excepting fasting glucose (Table 2). There was no
evidence that the DXA measures of total body fat were
more strongly associated with insulin, glucose, triglycer-
ides, or cholesterol in comparison to BMI or body fat
estimated through skinfolds in APCAPS (p for hetero-
geneity all >0.46) or IMS participants. Furthermore,
abdominal measures of adiposity (WHR, WC or DXA
L1-L4) did not demonstrate stronger associations with
any of the blood based cardiometabolic risk factors than
whole body measures of adiposity. All these associations
were largely unattenuated after multivariable adjustment
(data not shown). One quarter (25%, 95% CI 22-28%) of
the IMS sample had diabetes, of whom 71% were known
diabetics who did not undertake the oral glucose tolerance
test. We therefore did not analyse post-load glucose or in-
sulin levels in relation to anthropometric characteristics.
Measures of adiposity were also generally associated
with blood pressure (Table 3). There was no evidence
that the association with blood pressure measures were
stronger for DXA measures of total body fat as com-
pared to BMI, or skinfolds. Among IMS participants, the
abdominal measures of adiposity, in particular WHR,
tended to be more strongly related to SBP than the total
body measures of adiposity but there was no strong stat-
istical evidence for these differences (p all ≥0.06). This
was not apparent among the APCAPS participants.
Logistic regression analyses showed that diabetes, insu-
lin resistance and hypertension were associated with all
measures of adiposity among the IMS participants
(Table 4). For these three outcomes, this association was
not stronger for DXA whole body measures of adiposity
compared to BMI, or skinfold measures of body fat. There
was no clear evidence that abdominal adiposity measures
(WHR, WC and DXA) were more closely associated with
hypertension or insulin resistance than whole body mea-
sures. In contrast, diabetes had a particularly strong rela-
tionship with WHR and there was some statistical
evidence that this was stronger than the relationship with
DXA total fat, DXA L1L4 fat and BMI (p for all ≤ 0.03).
These associations were not attenuated after adjustment
for confounders. There were only 14 cases with IFG, and
so this outcome was not included in the analyses.
Table 2 Linear regressions showing adiposity in relation
to blood-based cardiometabolic risk factors
APCAPS IMS
Age and
sex adjusted
Coefficient
(95% CI)
P-value Age and
sex adjusted
Coefficient
(95% CI)
P-value
Insulina,b N = 1,325 N = 638
DXA Total fat (g) 1.20 (1.16, 1.24) <0.001 1.27 (1.21, 1.33) <0.001
BMI kg/m2 1.19 (1.15, 1.22) <0.001 1.29 (1.23, 1.35) <0.001
Body fat % (skinfolds) 1.18 (1.14, 1.21) <0.001 1.28 (1.22, 1.33) <0.001
DXA L1L4 fat (g) 1.18 (1.15, 1.22) <0.001 1.30 (1.24, 1.36) <0.001
WHR 1.09 (1.05, 1.12) <0.001 1.21 (1.15, 1.28) <0.001
Waist circumference 1.17 (1.14, 1.21) <0.001 1.31 (1.25, 1.37) <0.001
Fasting Glucosea,b N = 1,338 N = 650
DXA Total fat (g) 1.00 (0.99, 1.01) 0.93 1.02 (1.00, 1.03) 0.05
BMI kg/m2 1.00 (0.99, 1.00) 0.78 1.02 (1.001, 1.03) 0.04
Body fat % (skinfolds) 1.00 (0.99, 1.01) 0.97 1.02 (1.01, 1.04) 0.001
DXA L1L4 fat (g) 1.00 (1.00, 1.01) 0.73 1.02 (1.01, 1.04) 0.008
WHR 1.00 (0.99, 1.00) 0.29 1.03 (1.02, 1.05) <0.001
Waist circumference 1.00 (0.99, 1.01) 0.96 1.03 (1.01, 1.04) 0.001
Triglyceridesb N = 1,371 N = 794
DXA Total fat (g) 1.09 (1.07, 1.12) <0.001 1.04 (1.01, 1.07) 0.01
BMI kg/m2 1.10 (1.07, 1.12) <0.001 1.08 (1.05, 1.11) <0.001
Body fat % (skinfolds) 1.10 (1.08, 1.13) <0.001 1.07 (1.04, 1.11) <0.001
DXA L1L4 fat (g) 1.10 (1.08, 1.13) <0.001 1.08 (1.04, 1.11) <0.001
WHR 1.08 (1.06, 1.11) <0.001 1.11 (1.07, 1.15) <0.001
Waist circumference 1.10 (1.08, 1.12) <0.001 1.11 (1.08, 1.14) <0.001
Cholesterol N = 1,371 N = 794
DXA Total fat (g) 0.20 (0.15, 0.25) <0.001 0.07 (-0.005, 0.14) 0.07
BMI kg/m2 0.19 (0.14, 0.24) <0.001 0.07 (-0.005, 0.14) 0.07
Body fat % (skinfolds) 0.19 (0.14, 0.24) <0.001 0.12 (0.04, 0.20) 0.004
DXA L1L4 fat (g) 0.21 (0.16, 0.26) <0.001 0.12 (0.05, 0.19) 0.001
WHR 0.13 (0.09, 0.18) <0.001 0.13 (0.05, 0.21) 0.001
Waist circumference 0.20 (0.15, 0.24) <0.001 0.12 (0.05, 0.19) 0.001
Values Are Relative Increases in Biomarkers Per 1 Standard Deviation in
Adiposity Measure.
aExcludes individuals who were diabetic or not fasting.
bOutcome measures are log transformed so coefficients represent ratios of
geometric means.
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Further analyses including DXA measures (DXA per-
cent body fat, truncal fat, L2-L4 regions) and weight
were similar to other adiposity measures and were not
reported (data available on request).
Sensitivity analyses
There was consistent evidence among APCAPS for signifi-
cant effect modification by sex of the relationship between
cholesterol and adiposity measures: BMI (p = 0.007), WC
(p = 0.04), body fat from skinfolds (p = 0.01), DXA adipos-
ity (p = 0.02) and DXA abdominal measures (p = 0.004).
There was also evidence that the relationship between
SBP and adiposity measures was modified by sex among
the APCAPS participants including: BMI (p = 0.002),
WHR (p = 0.01), WC (p < 0.001), bodyfat from skinfolds
(p = 0.001), DXA adiposity (p < 0.005) and DXA abdom-
inal adiposity (p < 0.001). Stratifying these analyses by
gender showed that relationship between cholesterol
and SBP with anthropometric characteristics was weaker
in females than in males (Table 5). Effect modification was
not consistently apparent among IMS participants or for
the other measures of cardiometabolic risk.
Discussion
Our study included adults across a broad age spectrum and
urban and rural in Hyderabad, India, and assessed a range
of blood based markers of cardiometabolic risk and blood
pressure as well as conventional and DXA measures of adi-
posity. We found strong and consistent relationships be-
tween different adiposity measures and cardiometabolic risk
factors. There was a lack of evidence for better prediction of
prevalent cardiometabolic risk factors by DXA measures of
adiposity as opposed to BMI, or skinfold measures. There
was also no evidence that abdominal measures of adiposity
were more closely related to cardiometabolic risk factors,
excepting the relationship between WHR and diabetes.
Previous studies suggest that diabetes develops at lower
levels of BMI among Asians, including Indians, compared
to Whites [10,11]. The vulnerability of Indians to diabetes
and cardiovascular disease may be because of the higher
adiposity for a given BMI [12,14,16], predisposition to-
wards abdominal adiposity [20,21], or it may be independ-
ent of adiposity, for instance influenced by life course
factors [3,9,23], or genetic vulnerability [27-29]. This study
did not demonstrate that DXA measures, which more ac-
curately assess the amount of body fat, were more predict-
ive of prevalent cardiometabolic risk factors than BMI,
Table 3 Linear regressions showing adiposity in relation
to blood pressure
APCAPS IMS
Age and
sex adjusted
Coefficient
(95% CI)
P-value Age and
sex adjusted
Coefficient
(95% CI)
P-value
SBP N = 1,371 N = 644
DXA Total fat (g) 1.41 (0.91, 1.91) <0.001 1.01 (-0.23, 2.24) 0.11
BMI kg/m2 2.14 (1.57, 2.72) <0.001 1.59 (0.35, 2.83) 0.006
Body fat % (skinfolds) 1.72 (1.18, 2.26) <0.001 1.01 (-0.36, 2.40) 0.15
DXA L1L4 fat (g) 1.75 (1.24, 2.25) <0.001 1.69 (0.48, 2.89) 0.006
WHR 0.86 (0.24, 1.48) 0.007 2.66 (1.45, 3.88) <0.001
Waist circumference 2.16 (1.58, 2.74) <0.001 2.33 (1.08, 3.58) <0.001
DBP N = 1,371 N = 644
DXA Total fat (g) 2.71 (2.31, 3.11) <0.001 2.42 (1.62, 3.22) <0.001
BMI kg/m2 2.58 (2.18, 2.97) <0.001 2.52 (1.72, 3.34) <0.001
Body fat % (skinfolds) 2.65 (2.23, 3.07) <0.001 2.09 (1.18, 3.00) <0.001
DXA L1L4 fat (g) 2.82 (2.41, 3.23) <0.001 2.82 (2.03, 3.60) <0.001
WHR 1.05 (0.60, 1.52) <0.001 2.18 (1.36, 3.00) <0.001
Waist circumference 2.67 (2.27, 3.07) <0.001 2.91 (2.09, 3.74) <0.001
Values Are Relative Increases in Biomarkers Per 1 Standard Deviation in
Adiposity Measure.
DXA measures additionally adjusted for DXA machine, DXA total fat (grams)
and DXA L1L4 fat (grams) additionally adjusted for height.
Table 4 Logistic regressions showing adiposity in
relation to diabetes and insulin resistance within IMS
participants
Age and sex adjusted
odds ratio (95% CI)
Multivariable adjusted
odds ratio (95% CI)*
Diabetes N = 798 N = 798
DXA Total fat (g)** 1.19 (1.02, 1.39) 1.08 (0.90, 1.30)
BMI kg/m2 1.42 (1.21, 1.66) 1.36 (1.14, 1.63)
Body fat % (skinfolds) 1.54 (1.28, 1.84) 1.45 (1.18, 1.79)
DXA L1L4 fat (g)** 1.37 (1.17, 1.61) 1.27 (1.06, 1.52)
WHR 1.88 (1.53, 2.31) 1.85 (1.49, 2.30)
Waist circumference 1.67 (1.40, 2.00) 1.58 (1.31, 1.91)
Insulin resistance N = 581 N = 581
DXA Total fat (g)** 1.96 (1.63, 2.38) 1.89 (1.54, 2.33)
BMI kg/m2 2.10 (1.72, 2.55) 2.06 (1.68, 2.54)
Body fat % (skinfolds) 2.23 (1.78, 2.80) 2.14 (1.68, 2.73)
DXA L1L4 fat (g)** 2.13 (1.72, 2.64) 2.06 (1.64, 2.59)
WHR 1.97 (1.59, 2.45) 2.00 (1.60, 2.51)
Waist circumference 2.42 (1.92, 3.05) 2.41 (1.89, 3.08)
Hypertension N = 798 N = 798
DXA Total fat (g)** 1.43 (1.22, 1.68) 1.39 (1.17, 1.66)
BMI kg/m2 1.49 (1.27, 1.75) 1.46 (1.23, 1.74)
Body fat % (skinfolds) 1.47 (1.23, 1.75) 1.46 (1.20, 1.78)
DXA L1L4 fat (g)** 1.45 (1.24, 1.70) 1.41 (1.19, 1.68)
WHR 1.52 (1.29, 1.79) 1.45 (1.22, 1.73)
Waist circumference 1.61 (1.37, 1.89) 1.56 (1.31, 1.86)
*Adjusted for age, sex, smoking, SLI, total METS, alcohol, caloric intake.
**DXA measures additionally adjusted for DXA machine and height.
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or skinfold measures of adiposity. The few comparable
data from large population-based studies also fail to show
that DXA measures of adiposity are better predictors of
markers of diabetes or hypertriglyceridemia than simpler
conventional adiposity measures [37-41]. One potential
explanation is that BMI presents a composite index of
risk – reflecting adiposity, lean mass and height, and while
increased weight and shorter stature may contribute to-
wards increasing risk of cardiometabolic risk, increased
lean mass (which raises BMI) may protect from cardiome-
tablic risk [42]. This means that BMI may do better than
expected as an index of CVD risk because it captures
more than just adiposity.
We did not find evidence to suggest mediation of
vulnerability through excess abdominal adiposity since
markers of cardiometabolic risk, were not more closely
associated with abdominal adiposity markers than whole
body measures of adiposity. The exception was the
stronger relationship between WHR and diabetes than
with other adiposity measures. This field remains con-
troversial, as some studies show that abdominal adipos-
ity (e.g. WHR, WC) is more closely related to diabetes
and coronary disease than more general obesity mea-
sures (e.g. BMI) [20-22], while others do not show this
difference [43,44]. A large review showed that WC was
more strongly related than BMI to prevalent diabetes,
but did not observe this difference in the Asian studies
[45], while other reviews show that central adiposity
is more closely related to diabetes prevalence among
Asians [10,46].
The possibility that the vulnerability of people in India
to diabetes and its sequelae is unrelated to adiposity,
perhaps relating to genetic vulnerability [27,28,29] was
not explored with the current study design.
Strengths and limitations
A key strength was that both DXA scanning and conven-
tional anthropometry were undertaken. Furthermore, a
large age range was included, with participants from both
rural and urban areas. The study sample was relatively
large, and examined Indian people in India, rather than In-
dians in other countries. We included comprehensive as-
sessment of blood based cardiometabolic risk factors and
blood pressure, but not metabolic syndrome. Limitations
include the cross-sectional design and relatively low re-
sponse rate, which raises the possibility of selection bias as
some differences in characteristics were noted between re-
sponders and non-responders. There may also be limited
generalisability of the results to the Indian population
since the IMS participants were sampled from factories
and so were more affluent and more likely to be in stable
employment than the Indian population in general. DXA
cannot distinguish between visceral and subcutaneous fat,
which may confer different health risks. The cut-off used
for determination of outcomes were mostly based on
Western populations, which may not always be appropri-
ate for an Indian population. Additionally, the Durnin and
Womersley formula for calculation of body fat from skin-
folds [33], may not be appropriate for this ethnic group.
Conclusions
We did not demonstrate that DXA measures were better
predictors of prevalent cardiometabolic risk factors than
conventional measures of adiposity. This study found
evidence that WHR is more strongly associated with
markers of diabetes than total body adiposity.
Additional file
Additional file 1: Table S1. Correlation Coefficients Between
Anthropometric Measures: Males. Table S2. Correlation Coefficients
Between Anthropometric Measures: Females.
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Table 5 Linear regressions showing adiposity in relation
to cardiometabolic risk factors among APCAPS
participants stratified by sex
Men Women
Age and
sex adjusted
Coefficient
(95% CI)
P, value Age and
sex adjusted
Coefficient
(95% CI)
P-value
Cholesterol N = 959 N = 412
DXA Total fat (g) 0.24 (0.18, 0.30) <0.001 0.11 (0.03, 0.19) 0.01
BMI kg/m2 0.23 (0.17, 0.29) <0.001 0.10 (0.03, 0.18) 0.005
Bodyfat (skinfolds) 0.23 (0.17, 0.29) <0.001 0.10 (0.03, 0.18) 0.01
DXA L1L4 fat (g) 0.25 (0.19, 0.31) <0.001 0.10 (0.02, 0.18) 0.02
WHR 0.16 (0.10, 0.21) <0.001 0.07 (-0.01, 0.16) 0.08
Waist circumference 0.23 (0.17, 0.29) <0.001 0.13 (0.05, 0.20) 0.003
SBP N = 959 N = 412
DXA Total fat (g) 2.16 (1.60, 2.73) <0.001 0.17 (-0.80, 1.15) 0.73
BMI kg/m2 2.59 (1.99, 3.19) <0.001 1.00 (0.07, 1.93) 0.04
Bodyfat (skinfolds) 2.25 (1.70, 2.81) <0.001 0.39 (-0.58, 1.37) 0.39
DXA L1L4 fat (g) 2.40 (1.83, 2.97) <0.001 0.38 (-0.59, 1.35) 0.44
WHR 1.30 (0.70, 1.91) <0.001 -0.31 (-1.47, 0.85) 0.60
Waist circumference 2.72 (2.12, 3.32) <0.001 0.70 (-0.30, 1.69) 0.17
Values Are Relative Increases in Biomarkers Per 1 Standard Deviation in
Adiposity Measure.
DXA measures additionally adjusted for DXA machine, DXA total fat (grams)
and DXA L1L4 fat (grams) additionally adjusted for height. Sex specific
Z-scores were created for these analyses.
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